Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies, today announced the pricing of an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Histogenics Corporation Announces Pricing of Public Offering of Common Stock and WarrantsOctober 5, 2018 8:10 AM Histogenics (HSGX) Announces Proposed Common Share Public OfferingOctober 4, 2018 4:02 PM Histogenics Corporation Announces Proposed Public Offering of Common Stock and WarrantsOctober 4, 2018 4:01 PM